David V. Sheehan, MD, MBA: The Speed of Onset of Action of Alprazolam-XR Compared to Alprazolam-CT in Panic Disorder

Name: David V. Sheehan, MD, MBA: The Speed of Onset of Action of Alprazolam-XR Compared to Alprazolam-CT in Panic Disorder
SKU: 2763
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 40 No. 2 Articles Tags: alprazolam, b-a-raj, david-v-sheehan, duration-of-therapeutic-action, extended-release, kathy-harnett-sheehan, mba, md, onset-of-action, panic-disorder-during-pregnancy, phd, sustained-release

Description

David V. Sheehan, MD, MBA: The Speed of Onset of Action of Alprazolam-XR Compared to Alprazolam-CT in Panic Disorder

Description

David V. Sheehan, MD, MBA

ORIGINAL RESEARCH

The Speed of Onset of Action of Alprazolam-XR Compared to Alprazolam-CT in Panic Disorder

David V. Sheehan, MD, MBA, Kathy Harnett Sheehan, PhD, and B.A. Raj, MD

Sumeet Roy, PhD, MBA: Efficacy of Print Advertising for a Bipolar Disorder Study

Eileen P. Ahearn, MD, PhD: Fear, Anxiety, and the Neuroimaging of PTSD

Srinivas G. Rao, MD, PhD: Understanding The Fibromyalgia Syndrome

Strategies for Treatment-Resistant Depression

David V. Sheehan, MD, MBA: The Speed of Onset of Action of Alprazolam-XR Compared to Alprazolam-CT in Panic Disorder

Description

David V. Sheehan, MD, MBA

ORIGINAL RESEARCH

The Speed of Onset of Action of Alprazolam-XR Compared to Alprazolam-CT in Panic Disorder

David V. Sheehan, MD, MBA, Kathy Harnett Sheehan, PhD, and B.A. Raj, MD

Related products

Sumeet Roy, PhD, MBA: Efficacy of Print Advertising for a Bipolar Disorder Study

Eileen P. Ahearn, MD, PhD: Fear, Anxiety, and the Neuroimaging of PTSD

Srinivas G. Rao, MD, PhD: Understanding The Fibromyalgia Syndrome

Strategies for Treatment-Resistant Depression